Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Shareholders??? Equity

v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   40,618,766    
Beginning balance at Dec. 31, 2020 $ 123,149 $ 406 $ 326,390 $ (203,647)
Increase (Decrease) in Stockholders' Equity        
Net loss (21,699)     (21,699)
Stock-based compensation 9,410   9,410  
Issuance of restricted and performance stock units (in shares)   206,193    
Issuance of restricted and performance stock units 0 $ 2 (2)  
Exercise of stock options and employee stock purchase plan (in shares)   733,970    
Exercise of stock options and employee stock purchase plan 4,421 $ 7 4,414  
Ending balance (in shares) at Sep. 30, 2021   41,558,929    
Ending balance at Sep. 30, 2021 115,281 $ 415 340,212 (225,346)
Beginning balance (in shares) at Jun. 30, 2021   41,337,108    
Beginning balance at Jun. 30, 2021 118,703 $ 413 336,495 (218,205)
Increase (Decrease) in Stockholders' Equity        
Net loss (7,141)     (7,141)
Stock-based compensation 2,911   2,911  
Issuance of restricted and performance stock units (in shares)   67,249    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   154,572    
Exercise of stock options and employee stock purchase plan 808 $ 1 807  
Ending balance (in shares) at Sep. 30, 2021   41,558,929    
Ending balance at Sep. 30, 2021 $ 115,281 $ 415 340,212 (225,346)
Beginning balance (in shares) at Dec. 31, 2021 41,736,950 41,736,950    
Beginning balance at Dec. 31, 2021 $ 112,550 $ 417 342,765 (230,632)
Increase (Decrease) in Stockholders' Equity        
Net loss (23,533)      
Stock-based compensation 11,437   11,437  
Issuance of restricted and performance stock units (in shares)   315,275    
Issuance of restricted and performance stock units 0 $ 3 (3)  
Exercise of stock options and employee stock purchase plan (in shares)   219,998    
Exercise of stock options and employee stock purchase plan $ 991 $ 3 988  
Ending balance (in shares) at Sep. 30, 2022 42,272,223 42,272,223    
Ending balance at Sep. 30, 2022 $ 101,445 $ 423 355,187 (254,165)
Beginning balance (in shares) at Jun. 30, 2022   42,134,504    
Beginning balance at Jun. 30, 2022 101,690 $ 420 351,117 (249,847)
Increase (Decrease) in Stockholders' Equity        
Net loss (4,318)      
Stock-based compensation 3,849   3,849  
Issuance of restricted and performance stock units (in shares)   55,934    
Issuance of restricted and performance stock units 0 $ 1 (1)  
Exercise of stock options and employee stock purchase plan (in shares)   81,785    
Exercise of stock options and employee stock purchase plan $ 224 $ 2 222  
Ending balance (in shares) at Sep. 30, 2022 42,272,223 42,272,223    
Ending balance at Sep. 30, 2022 $ 101,445 $ 423 $ 355,187 $ (254,165)